EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Convalescent Plasma Therapy in Immunocompromised Patients Infected With the BA.1 or BA.2 Omicron SARS‐CoV‐2

Quentin Richier iD, Benjamin De Valence, Dorothée Chopin, Emmanuelle Gras, Laura I Levi, Yasmine Abi Aad, Jérôme Pacanowski, Jean-Luc Meynard, Léo Plaçais, Dorothée Fey, Priscille Couture, Guillaume Martin-Blondel und 10 weitere

Influenza and Other Respiratory Viruses · 2024

DOI: 10.1111/irv.13272 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Influenza and Other Respiratory Viruses, 2024. Verfasst von Quentin Richier und 21 weiteren Autor:innen. Beteiligte Einrichtung: Service de Maladies Infectieuses, Hôpital Saint-Antoine, AP-HP, Paris, France. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The emergence of SARS‐CoV‐2 Omicron variant has led to a complete reconfiguration of the therapeutic landscape, with all monoclonal antibodies having lost any neutralization activity. We report here a case series of 75 immunocompromised patients infected by the Omicron variant who benefited from COVID‐19 convalescent plasma (CCP). At Day 28, the overall survival was 76% (95% CI 67–86) with no significant difference in the clinical outcome between patients with hematological malignancies, solid organ transplantation or autoimmune diseases. No safety concern was reported during the course of the study. These results showed that CCP is well tolerated and represents a treatment option for immunocompromised patients who remain highly impacted by the COVID19 epidemic.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19HumansCOVID-19 SerotherapySARS-CoV-2Immunization, PassiveImmunocompromised HostAntibodies, ViralAntibodies, Neutralizing

Stichwörter der Autor:innen

COVID-19Omicron variantSARS-CoV-2convalescent plasmaimmunocompromised

Substanzen

Antibodies, ViralAntibodies, Neutralizing

Autor:innen und Institutionen

  • Service de Maladies Infectieuses, Hôpital Saint-Antoine, AP-HP, Paris, France.
  • Sorbonne Université, IPLESP, Inserm UMR-S1136, Paris, France.
  • Département de Médecine Interne et Immunologie clinique, Hôpital Bicêtre, Le Kremlin-Bicêtre, France.
  • Service de Médecine Interne, Hôpital Foch, Suresnes, France.
  • Service des Maladies Infectieuses et Tropicales, Centre Hospitalier Universitaire de Toulouse, Toulouse, France.
  • INSERM UMR1043, Centre de Physiopathologie de Toulouse-Purpan, Toulouse, France.

ORCID-Profile: Quentin Richier

Zitieren

APA

Richier, Q., De Valence, B., Chopin, D., Gras, E., Levi, L. I., Abi Aad, Y., Pacanowski, J., Meynard, J. L., Plaçais, L., Fey, D., Couture, P., Martin-Blondel, G., Pestre, V., Woessner, J., Ancellin, S., Weyrich, P., Carpentier, B., Idri, S., Tiberghien, P., …, & Lacombe, K. (2024). Convalescent Plasma Therapy in Immunocompromised Patients Infected With the BA.1 or BA.2 Omicron SARS‐CoV‐2. Influenza and Other Respiratory Viruses. https://doi.org/10.1111/irv.13272

Vancouver

Richier Q, De Valence B, Chopin D, Gras E, Levi LI, Abi Aad Y, et al. Convalescent Plasma Therapy in Immunocompromised Patients Infected With the BA.1 or BA.2 Omicron SARS‐CoV‐2. Influenza and Other Respiratory Viruses. 2024. doi:10.1111/irv.13272

BibTeX
@article{Richier2024,
  author = {Richier, Quentin and De Valence, Benjamin and Chopin, Dorothée and Gras, Emmanuelle and Levi, Laura I and Abi Aad, Yasmine and Pacanowski, Jérôme and Meynard, Jean-Luc and Plaçais, Léo and Fey, Dorothée and Couture, Priscille and Martin-Blondel, Guillaume and Pestre, Vincent and Woessner, Juliette and Ancellin, Sophie and Weyrich, Pierre and Carpentier, Benjamin and Idri, Salim and Tiberghien, Pierre and Surgers, Laure and Hueso, Thomas and Lacombe, Karine},
  title = {Convalescent Plasma Therapy in Immunocompromised Patients Infected With the BA.1 or BA.2 Omicron SARS‐CoV‐2},
  journal = {Influenza and Other Respiratory Viruses},
  year = {2024},
  doi = {10.1111/irv.13272}
}
Kostenlos starten →